Medicare Enrolled

Dr. Zahida Tayyib, M.D.

Psychiatry · Mountain View, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
2500 HOSPITAL DR STE 3A, Mountain View, CA 94040
6509696772
In practice since 2006 (19 years)
NPI: 1144251315 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Tayyib from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tayyib? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Tayyib

Dr. Zahida Tayyib is a psychiatry specialist in Mountain View, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Tayyib performed 674 Medicare services across 137 unique beneficiaries.

Between the years covered by Open Payments, Dr. Tayyib received a total of $7,390 from 27 pharmaceutical and/or device companies across 377 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatry. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Tayyib is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 22% volume in CA $7,390 industry payments

Medicare Practice Summary

Medicare Utilization ↗
674
Medicare services
Top 22% in CA for psychiatry
137
Unique beneficiaries
$104
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~35 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Magnetic field treatment to stimulate brain nerve cells
A procedure using a magnetic field to stimulate nerve cells in the brain, including the delivery and management of the treatment.
329 $118 $400
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
172 $79 $200
45-minute psychotherapy and evaluation visit
A 45-minute session that includes both psychotherapy and an evaluation and management visit.
96 $78 $350
Family psychotherapy, 50 minutes
A 50-minute therapy session involving the patient and their family members to address psychological or behavioral concerns.
32 $80 $250
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
27 $154 $300
Magnetic brain stimulation with motor threshold determination
A procedure using magnetic fields to stimulate nerve cells in the brain. It includes determining the motor threshold and managing the delivery of the treatment.
18 $195 $500
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,390
Total received (2018-2024)
Avg $1,056/year across 7 years
Top 7% in CA for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
377
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,314 (99.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$76 (1.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,197
2023
$1,724
2022
$1,019
2021
$275
2020
$377
2019
$1,515
2018
$1,283

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Teva Pharmaceuticals USA, Inc.
$321
ABBVIE INC.
$269
Alkermes, Inc.
$100
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$88
Neurocrine Biosciences, Inc.
$61
Bausch Health US, LLC
$58
Almatica Pharma LLC
$56
Supernus Pharmaceuticals, Inc.
$56
Lundbeck LLC
$53
Noven Therapeutics, LLC
$49
Otsuka America Pharmaceutical, Inc.
$43
Takeda Pharmaceuticals U.S.A., Inc.
$42
Top 3 companies account for 57.6% of 2024 payments
All-time payments by company (2018-2024) ›
Lundbeck LLC
$1,035
Teva Pharmaceuticals USA, Inc.
$753
ABBVIE INC.
$598
Sunovion Pharmaceuticals Inc.
$542
Allergan Inc.
$499
Takeda Pharmaceuticals U.S.A., Inc.
$484
AbbVie Inc.
$481
Alkermes, Inc.
$456
Neurocrine Biosciences, Inc.
$419
Vanda Pharmaceuticals Inc.
$403
ITI, Inc.
$319
Otsuka America Pharmaceutical, Inc.
$287
Bausch Health US, LLC
$201
Janssen Pharmaceuticals, Inc
$181
Indivior Inc.
$127
Supernus Pharmaceuticals, Inc.
$97
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$88
Shire North American Group Inc
$76
Adlon Therapeutics L.P.
$70
Avanir Pharmaceuticals, Inc.
$57
Almatica Pharma LLC
$56
Noven Therapeutics, LLC
$49
Allergan, Inc.
$36
Corium, LLC
$25
IDORSIA PHARMACEUTICALS US INC
$22
Merck Sharp & Dohme Corporation
$16
Vertical Pharmaceuticals, LLC
$12
Top 3 companies account for 32.3% of all-time payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · ADHANSIA XR · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Austedo XR · BELSOMRA · BRINTELLIX · BYSTOLIC · CAPLYTA · Fanapt · HETLIOZ · INGREZZA · LATUDA · LOREEV XR · METHYLPHENIDATE 72 · MYDAYIS · Nuedexta · PERSERIS · QELBREE · QUVIVIQ · Qelbree · REXULTI · SPRAVATO · SUBLOCADE · SUBOXONE SUBLINGUAL FILM · TRINTELLIX · Trintellix · UZEDY · VIIBRYD · VRAYLAR · VYVANSE · WELLBUTRIN XL · Xelstrym
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for psychiatry in CA.

Looking for a psychiatry specialist in Mountain View?
Compare psychiatrists in the Mountain View area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists within 10 mi
879
Per 100K population
46.2
County median income
$159,674
Nearest hospital
EL CAMINO HEALTH
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Tayyib is a clinical cardiology specialist, with above-average Medicare volume (top 22% in CA), with low-engagement industry engagement in the top 7% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Tayyib experienced with magnetic field treatment to stimulate brain nerve cells?
Based on Medicare claims data, Dr. Tayyib performed 329 magnetic field treatment to stimulate brain nerve cells services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tayyib receive payments from pharmaceutical companies?
Yes. Dr. Tayyib received a total of $7,390 from 27 companies across 377 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tayyib's costs compare to other psychiatrists in Mountain View?
Dr. Tayyib's average Medicare payment per service is $104. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tayyib) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →